Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $43,680,000.00 in Stock

Posted by Brenda Bartman on Jun 8th, 2026

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Paul Vigano sold 7,000,000 shares of the stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at $1,578,089.76. This trade represents a 96.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $6.68 on Monday. The stock’s fifty day simple moving average is $6.79 and its 200 day simple moving average is $7.71. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 5.66, a PEG ratio of 0.75 and a beta of 1.93. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.73 and a 52-week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $647.92 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on AVAH. Barclays reduced their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. Truist Financial boosted their target price on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research note on Wednesday, May 20th. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a report on Friday, March 20th. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday. Finally, Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare has an average rating of “Moderate Buy” and an average target price of $10.50.

Get Our Latest Stock Analysis on Aveanna Healthcare

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd lifted its holdings in shares of Aveanna Healthcare by 8.9% during the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after buying an additional 1,151 shares during the last quarter. Barclays PLC increased its holdings in Aveanna Healthcare by 0.8% in the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after buying an additional 1,366 shares during the last quarter. Franklin Resources Inc. raised its position in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after acquiring an additional 1,528 shares in the last quarter. Intech Investment Management LLC raised its position in Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners lifted its stake in Aveanna Healthcare by 13.5% in the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after acquiring an additional 2,007 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.